PFIZERBSEPFIZER LTD· PharmaceuticalsLowNeutral
Announced Mon, 26 Oct, 2026 · 18:50 IST

Board meeting set for November 3 to approve quarterly and half-year results

PFIZER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.6%Reaction day
₹3695.00
prior close
₹3699.00
announcement price
After-mkt
timing
Nifty Microcap 250marketpendingvs market: pending
Pharmaceuticals peers, median of 173sector+2.0%-1.4% vs sector

On the reaction day the stock moved 1.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.1
10m
-1.5
15m
-1.5
30m
-1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.6pendingpending+2.0-1.4
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Pfizer Limited will hold a Board meeting on November 3, 2026 to approve its unaudited financial results for the quarter and six-month period ended September 30, 2026. The trading window remains closed until 48 hours after the results are made public. No results or financial figures were included in this notice.

Likely market impact

Results are pending, so no earnings direction is given. The trading window remains closed for 48 hours after publication, and volatility may rise when results are released.